登革熱Denque Fever
編輯歷史
| 時間 | 作者 | 版本 |
|---|---|---|
| 2017-07-17 16:31 – 16:31 | r0 – r1 | |
顯示 diff+ 登革熱Denque Fever
+ https://en.wikipedia.org/wiki/Wikipedia:WikiProject_Medicine/Translation_task_force/RTT/Simple_Dengue_fever
+
+
+ Dengue fever is a mosquito-borne tropical disease caused by the dengue virus.[1]Symptoms typically begin three to foreteen days after infection.[2] This may include a high fever,headache, vomiting, muscle and joint pains, and a characteristic skin rash.[1][2] Recovery generally takes less two to seven days.[1] In a small proportion of cases, the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs.[2]
+ 登革熱 (Dengue fever)，是一種蚊蟲傳播的熱帶疾病，主要致病源則是登革病毒 (dengue virus) [1]。症狀通常在感染的三到十四天後開始出現[2]。這些臨床症狀大概包括高燒、頭痛、嘔吐、肌肉與關節疼痛，還伴隨皮膚紅疹[1][2]。
+ Dengue is spread by several species of mosquitoof the Aedes type, principally A. aegypti.[1] The virus has five different types;[3] infection with one type usually gives lifelong immunity to that type, but only short-term immunity to the others. Subsequent infection with a different type increases the risk of severe complications.[1] A number of tests are available to confirm the diagnosis including detectingantibodies to the virus or its RNA.[2]
+ 登革熱多是藉著斑紋屬的病媒蚊所傳播，主要是埃及斑蚊[1] 。
+
+ As of December 2015 a vaccine for dengue fever has been approved in three countries, but it is not yet commercially available.[4] Prevention is by reducing mosquito habitat and limiting exposure to bites. This may be done by getting rid of or covering standing water and wearing clothing that covers much of the body.[1] Treatment of acute dengue is supportive and includes giving fluid either by mouth or intravenously for mild or moderate disease. For more severe cases blood transfusion may be required.[2] About half a million people require admission to hospital a year.[1] Nonsteroidal anti-inflammatory drug(NSAIDs) such as ibuprofen should not be used.[2]
+
+
+ Dengue has become a global problem since the Second World War and is common in more than 110 countries.[5][6] Each year between 50 and 528 million people are infected and approximately 20,000 die.[7][8][9] The earliest descriptions of an outbreak date from 1779.[6] Its viral cause and spread were understood by the early 20th century.[10] Apart from eliminating the mosquitoes, work is ongoing for medication targeted directly at the virus.[11]
+
+ *1."Dengue and severe dengue Fact sheet N°117". WHO. May 2015. Retrieved3 February 2016.
+ *2. Kularatne, SA (15 September 2015). "Dengue fever.". BMJ (Clinical research ed.)351: h4661. PMID 26374064.
+ *3. Normile D (2013). "Surprising new dengue virus throws a spanner in disease control efforts".Science 342 (6157): 415. doi:10.1126/science.342.6157.415. PMID 24159024.
+ *4.Maron, Dina (December 30, 2015). "The mosquito-borne disease afflicts millions, and has had no approved vaccine until now". Scientific America. Retrieved 3 February 2016.
+ *5. Ranjit S, Kissoon N (January 2011). "Dengue hemorrhagic fever and shock syndromes".Pediatr. Crit. Care Med. 12 (1): 90–100. doi:10.1097/PCC.0b013e3181e911a7.PMID 20639791.
+ *6. Gubler DJ (July 1998). "Dengue and dengue hemorrhagic fever". Clin. Microbiol. Rev. 11(3): 480–96. PMC 88892. PMID 9665979.
+ *7.Whitehorn J, Farrar J (2010). "Dengue". Br. Med. Bull. 95: 161–73.doi:10.1093/bmb/ldq019. PMID 20616106.
+ *8.Bhatt S, Gething PW, Brady OJ, et al. (April 2013). "The global distribution and burden of dengue". Nature 496 (7446): 504–7. doi:10.1038/nature12060. PMC 3651993.PMID 23563266.
+ *9. Carabali, M; Hernandez, LM; Arauz, MJ; Villar, LA; Ridde, V (30 July 2015). "Why are people with dengue dying? A scoping review of determinants for dengue mortality.". BMC infectious diseases 15: 301. PMID 26223700.
+ *10. Henchal EA, Putnak JR (October 1990). "The dengue viruses". Clin. Microbiol. Rev. 3 (4): 376–96. doi:10.1128/CMR.3.4.376. PMC 358169. PMID 2224837.
+ *11. Noble CG, Chen YL, Dong H; et al. (March 2010). "Strategies for development of Dengue virus inhibitors". Antiviral Res. 85 (3): 450–62. doi:10.1016/j.antiviral.2009.12.011.PMID 20060421.
|
||